New Jersey S 446: Requires health benefits plans to cover abuse-deterrent opioid analgesic drug products.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: S 446

Sponsors: Stack, Brian P.

View New Jersey S 446 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.